top of page
The latest from NuvOx
Search
NuvOx’s Co-Founder, Dr. Evan Unger, Receives 2024 Harry Fischer Award for Excellence in Contrast Media Research
Tucson, AZ – October 9, 2024 - Dr. Evan Unger, Executive Chairman of NuvOx Therapeutics (NuvOx), has been awarded the 2024 Harry Fischer...
Oct 14, 2024
NuvOx Pharma LLC Announces Receipt of Qualified Person’s Declaration Equivalence to UK / EU GMP for Investigational Medical Products
Tucson, AZ, September 6th, 2024 – NuvOx Pharma LLC, a wholly owned subsidiary of NuvOx Therapeutics Inc. (together, “NuvOx”) announced...
Sep 17, 2024
NuvOx Pharma LLC Announces Authorization of ARDS Trial from Health Canada
Tucson, AZ, June 30th, 2024 – NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND:...
Jul 11, 2024
NuvOx Pharma Announces Issuance of a New Patent
Tucson, AZ, January 2, 2024 - NuvOx Pharma has been issued US Patent No. 11,857,627, entitled “Fractionated Radiotherapy and...
Jan 8, 2024
NuvOx Announces Contract to Support NOVEL Trial
Tucson, AZ, USA, October 31, 2023 - NuvOx Pharma (NuvOx), a clinical stage biotechnology company developing a first-in-class therapeutic...
Nov 2, 2023
bottom of page